Flow conditions modulate homocysteine induced changes in the expression of endothelial cell genes associated with cell-cell interaction and cytoskeletal rearrangement

Thrombosis and Haemostasis

Volumn 88, Issue 6, 2002, Pages 1047-1053

  Dardik, Rima ^a   Savion, Naphtali ^b   Gal, Nurit ^a   Varon, David ^c  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Alpha catenin; Cell cell junctions; Endothelial cells; Homocysteine; Profilin

Indexed keywords

ACTIN; ALPHA CATENIN; BETA ACTIN; CADHERIN; COMPLEMENTARY DNA; ENDOGLIN; GAP JUNCTION ALPHA 1 PROTEIN; GAP JUNCTION PROTEIN; HOMOCYSTEINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROFILIN; PROFILIN I; RNA; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; BLOOD FLOW; CARDIOVASCULAR SYSTEM; CELL DAMAGE; CELL INTERACTION; CELL JUNCTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FLOW KINETICS; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; UPREGULATION; WESTERN BLOTTING;

EID: 0036912753     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613353     Document Type: Article

References (22)

1. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 1993; 13: 1327-33.
2. Dardik R, Varon D, Tamarin I, Zivelin A, Salomon O, Shenkman B, Savion N. Homocysteine and oxidized low density lipoprotein enhance platelet adhesion to endothelial cells under flow conditions: Distinct mechanisms of thrombogenic modulation. Thromb Haemost 2000; 83: 338-44.
3. Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986; 77: 1909-16.
4. Nishinaga M, Ozawa T, Shimada K. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine endothelial cells. J Clin Invest 1993; 92: 1381-86.
5. Wang J, Dudman NPB, Wilcken DEL. Effects of homocysteine and related compounds on prostacyclin production by cultured human vascular endothelial cells. Thromb Haemost 1993; 70: 1047-52.
6. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Myullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: 308-18.
7. Sung FL, Siow YL, Wang G, Lynn EG, Karmin O. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis. Mol Cell Biochem 2001; 216: 121-8.
8. Kokame K, Kato H, Miyata T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis: GRP78/BiP and novel genes. J Biol Chem 1996; 271: 29659-65.
9. Outinen PA, Sood SK, Liaw PCY, Sarge KD, Maeda N, Hirsh J, Ribau J, Podor TJ, Weitz JI, Austin RC. Characterization of the stress-inducing effects of homocysteine. Biochem J 1998; 332: 213-21.
10. Outinen PA, Sood SK, Pfeifer SI, Pamidi S, Podor TJ, Li J, Weitz JL, Austin RC. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 1999; 94: 959-67.
11. 2-terminal kinase and promoter response element. Blood 2000; 96: 2140-8.
12. Gardena-Garcia G, Comander J, Anderson KR, Blackman BR, Gimbrone MA Jr. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci USA 2001; 98: 4478-85.
13. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-56.
14. Varon D, Dardik R, Shenkman B, Kotev-Emeth S, Farzame N, Tamarin I, Savion N. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997; 85: 283-94.
15. Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay J, Introna M, Gulino D, Lampugnani MG, Dejana E. Functional properties of human vascular endothelial cadherin (7B4/Cadherin-5), an endothelium-specific cadherin. Arter Thromb Vasc Biol 1995; 15: 1229-39.
16. Theriot JA, Mitchison TJ. The three faces of profilin. Cell 1993; 75: 835-38.
17. Kang F, Purich DL, Southwick FS. Profilin promotes barbed-end actin filament assembly without lowering the critical concentration. J Biol Chem 1999; 274: 36963-72.
18. Goldschmidt-Clermont P, Kim JW, Machesky JM, Rhee SG, Pollard TD. Regulation of phospholipase C-γ1 by profilin and tyrosine phosphorylation. Science 1991; 251: 1231-33.
19. Theriot JA, Rosenblatt J, Portnoy DA, Goldschmidt-Clermont PJ, Mitchison TJ. Involvement of profiling in the actin-based motility of L. monocytogenes in cells and cell-free extracts. Cell 1994; 76: 505-17.
20. Witke W, Sutherland JD, Sharpe A, Arai M, Kwiatkowski DJ. Proflin I is essential for cell survival and cell division in early mouse development. Proc Natl Acad Sci USA 2001; 98: 3832-6.
21. Janke J, Schluter K, Jandrig B, Theile M, Kolble K, Arnold W, Grinstein E, Schwartz A, Estevez-Schwarz L, Schlag PM, Jockusch BM, Scherneck S. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin I. J Exp Med 2000; 191: 1675-85.
22. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990; 136: 1229-33.